A carregar...
Checkpoint Inhibitors in Breast Cancer - Current Status and Future Directions
Antineoplastic agents directly targeting tumor cells have represented the major strategy of systemic anticancer therapy for many years. Nevertheless, overcoming resistance mechanisms remains a great challenge because treatment options are limited in many cases. From this point of view, immunotherape...
Na minha lista:
| Publicado no: | Breast Care (Basel) |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
S. Karger GmbH
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6016055/ https://ncbi.nlm.nih.gov/pubmed/29950964 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000486706 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|